BSE Live
Dec 31, 16:01Prev. Close
0.82
Open Price
0.83
Bid Price (Qty.)
0.75 (231309)
Offer Price (Qty.)
0.76 (306620)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Remedium Lifecare (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.77 | 0.02 | 0.04 | 0.01 | 0.03 | |
| Diluted EPS (Rs.) | 0.77 | 0.02 | 0.04 | 0.01 | 0.03 | |
| Cash EPS (Rs.) | 0.81 | 0.02 | 0.04 | 0.01 | 0.06 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 9.32 | 8.55 | 8.52 | 8.44 | 8.45 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 9.32 | 8.55 | 8.52 | 8.44 | 8.45 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 8.03 | 0.44 | 0.97 | 3.70 | 10.93 | |
| PBDIT/Share (Rs.) | 1.08 | 0.05 | 0.05 | 0.02 | 0.08 | |
| PBIT/Share (Rs.) | 1.04 | 0.05 | 0.05 | 0.01 | 0.06 | |
| PBT/Share (Rs.) | 1.04 | 0.05 | 0.05 | 0.01 | 0.03 | |
| Net Profit/Share (Rs.) | 0.77 | 0.02 | 0.04 | 0.01 | 0.03 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 13.42 | 12.06 | 5.25 | 0.42 | 0.75 | |
| PBIT Margin (%) | 12.97 | 12.06 | 4.85 | 0.31 | 0.51 | |
| PBT Margin (%) | 12.97 | 12.06 | 4.80 | 0.29 | 0.27 | |
| Net Profit Margin (%) | 9.58 | 5.02 | 3.91 | 0.25 | 0.27 | |
| Return on Networth / Equity (%) | 8.25 | 0.26 | 0.44 | 0.11 | 0.36 | |
| Return on Capital Employed (%) | 10.07 | 0.60 | 0.55 | 0.13 | 0.36 | |
| Return on Assets (%) | 6.48 | 0.22 | 0.43 | 0.10 | 0.23 | |
| Total Debt/Equity (X) | 0.11 | 0.02 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 67.70 | 4.51 | 11.16 | 40.47 | 85.96 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 7.38 | 9.44 | 31.75 | 9.14 | 2.42 | |
| Quick Ratio (X) | 6.10 | 8.89 | 31.75 | 9.14 | 1.88 | |
| Inventory Turnover Ratio (X) | 4.12 | 0.78 | 0.00 | 0.00 | 4.73 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 7.47 | 4.56 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 2.58 | 28.66 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 19.25 | 237.46 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 2.78 | 34.96 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 2.39 | 1.81 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 2.78 | 35.03 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
27.11.2025
Remedium Lifeca Standalone September 2025 Net Sales at Rs 8.58 crore, down 65.8% Y-o-Y
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
27.11.2025
Remedium Lifeca Standalone September 2025 Net Sales at Rs 8.58 crore, down 65.8% Y-o-Y
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017